Our Team

  • Image Alt Text

    Maciej Trzaskowski

    Co-founder and Managing Director
    An ex-academic with a Doctor of Philosophy (Ph. D.) in statistical genetics from King's College London. Seasoned AI researcher and former Head of Research at Max Kelsen.

  • Michal Studzinski

    Co-Founder
    Brings a wealth of experience in delivering large- scale infrastructure and building projects across Australia, the UK, and Ireland..

  • Vinnie D'Alessandro

    Chief Commercial Officer
    An award-winning executive with over 25 years of experience driving innovation and growth in the fintech and technology sectors.

  • Kamran Healy-Sheeraz

    ML/DevOps Engineer
    Graduate from The University of Queensland with a degree in Computer Science, specialising in Machine Learning.

Our Advisory Board

  • Image Alt Text

    Chris Burnett

    Advisory Board Member
    Chris is a seasoned Company Director, Strategy Adviser, and Executive Coach with over 20 years’ board-level experience, having served as CEO/MD or Chair on fourteen boards around the world.

  • Dr Carrie Hillyard AM

    Advisory Board Member
    Dr. Hillyard is a highly respected director and mentor in the life sciences sector, with a career spanning medical research in London, groundbreaking diagnostic inventions in Brisbane, and co-founding venture capital firm CM Capital Investments. She has chaired multiple boards, including Mater Research Advisory Board and Fitgenes Australia, and the Board of Directors at Ketim Therapeutics.

  • Robert Golladay

    Advisory Board Member
    Robert is an accomplished executive at IBM, specialising in AI, business automation, process mining, cybersecurity, and information technology. He has a proven record of guiding organizations toward innovative, tech-driven solutions and achieving strategic growth across diverse global markets.

  • Dr Scott Fry

    Advisory Board Member
    COO of Vaxxas and Ph.D. graduate in Immunology from the University of Southern Queensland with early research work at the University of Queensland, Dr Fry has also been instrumental in commercialising rapid diagnostic tests and ELISAs.